Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology.

What Was Tested

This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Eighty-five children completed the 1-year study.

Four factors predicted response to therapy: growth velocity prior to GH therapy, glomerular filtration rate (GFR) at the start, mode of corticosteroid administration, and degree of insulin resistance.

Who Took Part

According to the abstract, 1993, children were involved.

By PubMed's age tags, the people studied were children and teenagers, both men and women.

How the Study Was Run

In design terms this was a randomized and double-blind study.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the children nor the staff measuring them knew who was on Exogenous HGH, sermorelin & older GHRPs (why they're passed over), so expectations could not easily colour the readings.

What Was Measured

Topics PubMed links to this paper include Calcium, Glucose Tolerance Test, Graft Rejection, Growth, Growth Disorders, Human Growth Hormone and Kidney Function Tests.

What This Means in Plain Language

The paper is a randomized and double-blind study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 1993, children.

With several hundred people or more, it is a fairly large study for this kind of research.

The publication is from 1998 (Pediatric nephrology (Berlin, Germany)), a journal based in Germany.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.